Marko Radic, PhD, associate professor of Microbiology, Immunology, and Biochemistry in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has published a paper in Science Translational Medicine that explores a novel treatment option for Systemic lupus erythematosus (SLE) using a targeted immunotherapy approach. According to the Centers for Disease Control… Read More
Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More
Glaucoma is the leading cause of irreversible blindness in the world and affects more than three million people in the United States each year. Currently, there is no cure for this crippling disease, only the option to treat one’s symptoms. Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine… Read More
Liza Makowski, PhD, professor of Medicine in the Division of Hematology and Oncology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has published a paper in the Journal of Immunology that provides novel insights into the biochemistry of the sugar glucose in immune cells critical to obesity and heart… Read More
When it comes to scientific research, it is not uncommon for investigators to be collaborating only with other researchers from within their own lab, department, or College. According to Glen E. Palmer, PhD, associate professor in the College of Pharmacy at the University of Tennessee Health Science Center (UTHSC), the Collaborative Research Network (CORNET) Awards… Read More
CTN2 marks significant milestone in its effort to grow the clinical research base at the University of Tennessee Health Science Center The Clinical Trials Network of Tennessee (CTN2) is kicking off its inaugural clinical trial, the first in the network’s efforts to grow the clinical research volume at the University of Tennessee Health Science Center… Read More
